RESUMO
BACKGROUND AND OBJECTIVE: Tobacco use is associated with increased periodontal destruction in both cigarette smokers and smokeless tobacco users. Gingival keratinocytes are the first cells in contact with microbial and tobacco components and play a key role in the innate immune response to these agents. The objective of this study was to evaluate the effect of nicotine and bacterial lipopolysaccharide (LPS) alone and in combination on gingival keratinocyte production of interleukin-1 alpha (IL-1 alpha) and interleukin-8 (IL-8). MATERIAL AND METHODS: Gingival keratinocyte cultures were established from 10 healthy, non-tobacco-using subjects. The cells were stimulated for 24 h with 1 mum or 1 mm nicotine and/or 10 microg/mL Escherichia coli or Porphyromonas gingivalis LPS. Interleukin-1 alpha and IL-8 proteins were quantified using ELISAs. RESULTS: Compared with untreated cultures, 1 mm nicotine stimulated production of IL-1 alpha (p < 0.001); E. coli and P. gingivalis LPS increased IL-8 production (p = 0.0014 and p = 0.0232, respectively). A combination of nicotine and LPS produced the highest cytokine quantities. Amounts of IL-1 alpha and IL-8 following 1 mm nicotine and LPS exposure were significantly greater than in untreated cultures (p < 0.001). Interleukin-8 was also responsive to 0.1 mum nicotine combined with E. coli or P. gingivalis LPS compared with control cultures (p < 0.0001 and p = 0.0029, respectively). Both cytokines tended to be elevated following the combined treatment relative to nicotine or LPS treatment alone. CONCLUSION: These results demonstrate that nicotine and LPS differentially regulate IL-1 and IL-8 production by gingival keratinocytes. Combined treatment tended to elevate cytokine production further, which may have implications for the progression of periodontitis in tobacco users.
Assuntos
Gengiva/efeitos dos fármacos , Interleucina-1alfa/análise , Interleucina-8/análise , Queratinócitos/efeitos dos fármacos , Lipopolissacarídeos/farmacologia , Nicotina/farmacologia , Agonistas Nicotínicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Sinergismo Farmacológico , Escherichia coli/fisiologia , Gengiva/citologia , Gengiva/imunologia , Humanos , Mediadores da Inflamação/farmacologia , Queratinócitos/imunologia , Porphyromonas gingivalis/fisiologia , Fatores de TempoRESUMO
BACKGROUND AND OBJECTIVE: Cytokines and chemokines play an important role in the pathogenesis of periodontal diseases. The objective of this study was to quantitatively assess the effect of initial periodontal therapy on gingival crevicular fluid levels of a comprehensive panel of cytokines and chemokines, including several less extensively studied mediators. MATERIAL AND METHODS: Clinical examinations were performed and gingival crevicular fluid samples obtained from six subjects with generalized severe chronic periodontitis prior to initial periodontal therapy and at re-evaluation (6-8 weeks). Four diseased and two healthy sites were sampled in each subject. Twenty-two gingival crevicular fluid mediators were examined using a multiplex antibody capture and detection platform. Statistical analyses were performed by fitting mixed effects linear models to log-transformed gingival crevicular fluid values. RESULTS: Gingival crevicular fluid interleukin (IL)-1alpha and IL-1beta were the only cytokines to differ in initially diseased vs. initially healthy sites. Following initial therapy, 13 of the 16 detectable cytokines and chemokines decreased significantly in diseased sites, including IL-1alpha, IL-1beta, IL-2, IL-3, IL-6, IL-7, IL-8, IL-12 (p40), CCL5/regulated on activation, normally T cell expressed and secreted (RANTES), eotaxin, macrophage chemotactic protein-1, macrophage inflammatory protein-1alpha and interferon-gamma. At healthy sites, only three of the 16 mediators were significantly altered following therapy. CONCLUSION: This is the first study, to our knowledge, to evaluate such an extensive panel of gingival crevicular fluid mediators within the same sample prior to and following initial therapy. The results confirm that periodontal therapy effectively reduces pro-inflammatory cytokines and chemokines, including less well-described mediators that may be important in initiation and progression of periodontitis. The multiplex assay will prove useful for future gingival crevicular fluid studies.
Assuntos
Periodontite Crônica/terapia , Citocinas/análise , Líquido do Sulco Gengival/química , Adulto , Idoso , Quimiocina CCL2/análise , Quimiocina CCL3/análise , Quimiocina CCL5/análise , Quimiocinas/análise , Quimiocinas CC/análise , Seguimentos , Hemorragia Gengival/terapia , Retração Gengival/terapia , Humanos , Mediadores da Inflamação/análise , Interferon gama/análise , Interleucina-12/análise , Interleucina-1alfa/análise , Interleucina-1beta/análise , Interleucina-2/análise , Interleucina-3/análise , Interleucina-6/análise , Interleucina-7/análise , Interleucina-8/análise , Pessoa de Meia-Idade , Perda da Inserção Periodontal/terapia , Bolsa Periodontal/terapia , Projetos PilotoRESUMO
INTRODUCTION: Human beta-defensins (HBDs) are cationic, antimicrobial peptides produced by epithelial cells and involved in various aspects of the innate and acquired immune responses. They are expressed by oral tissues as constitutive and inducible genes. Recently, single nucleotide polymorphisms (SNPs) of beta-defensins have been correlated with increased susceptibility to certain diseases. Studies have reported altered expression of beta-defensins in cancers suggesting their involvement in carcinogenesis. The purpose of this study was to evaluate the regulation of HBD-1 (also published as DEFB1), HBD-2 (DEFB4) and HBD-3 (DEFB103A) (http://www.genenames.org/index.html) and HBD-1 SNPs in oral squamous cell carcinoma cell lines (OSCC) and healthy gingival keratinocytes. METHODS: beta-defensin expression was quantitatively assessed using real-time polymerase chain reactions in OSCC and control cell lines after exposure to interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma. Control data were obtained in a previous study. DNA from 19 OSCC cell lines and 44 control subjects were extracted and the HBD-1 region spanning the 5' untranslated region to the first intron was sequenced and analysed for SNP identification and distribution. RESULTS: HBD-1 and HBD-2 basal messenger RNA expression were significantly lower in OSCC. In addition, the ability to be induced was significantly reduced in OSCC for all three beta-defensins. Four HBD-1 SNPs were differentially distributed between cancer and control populations. Genotype distribution at the HBD-1 locus also suggested loss of heterozygosity in OSCC. CONCLUSIONS: The genetic variation observed in OSCC compared with that in control cell lines may account for differences in beta-defensin expression. These results suggest a putative role for beta-defensins in carcinogenesis and indicate that beta-defensins may be useful markers of OSCC.
Assuntos
Peptídeos Catiônicos Antimicrobianos/genética , Carcinoma de Células Escamosas/genética , Neoplasias Bucais/genética , Polimorfismo de Nucleotídeo Único/genética , beta-Defensinas/genética , Regiões 5' não Traduzidas/genética , Linhagem Celular Tumoral , DNA de Neoplasias/genética , Éxons/genética , Regulação Neoplásica da Expressão Gênica/genética , Frequência do Gene/genética , Genótipo , Gengiva/citologia , Gengiva/metabolismo , Haplótipos/genética , Humanos , Interferon gama/farmacologia , Interleucina-1beta/farmacologia , Íntrons/genética , Queratinócitos/metabolismo , Desequilíbrio de Ligação/genética , Perda de Heterozigosidade/genética , RNA Mensageiro/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
Epithelial beta-defensins are broad-spectrum cationic antimicrobial peptides that also act as chemokines for adaptive immune cells. In the human genome, all known defensin genes cluster to a <1 Mb region of chromosome 8p22-p23. To identify new defensin genes, the DNA sequence from a contig of large-insert genomic clones from the region containing human beta-defensin-2 (HBD-2) was analyzed for the presence of defensin genes. This sequence survey identified a novel beta-defensin, termed HBD-3. The HBD-3 gene contains two exons, is located 13 kb upstream from the HBD-2 gene, and it is transcribed in the same direction. A partial HBD-3 cDNA clone was amplified from cDNA derived from IL-1beta induced fetal lung tissue. The cDNA sequence encodes for a 67 amino acid peptide that is approximately 43% identical to HBD-2 and shares the beta-defensin six cysteine motif. By PCR analysis of two commercial cDNA panels, HBD-3 expression was detected in adult heart, skeletal muscle, placenta and in fetal thymus. From RT-PCR experiments, HBD-3 expression was observed in skin, esophagus, gingival keratinocytes, placenta and trachea. Furthermore, in fetal lung explants and gingival keratinocytes, HBD-3 mRNA expression was induced by IL-1beta. Additional sequence analysis identified the HE2 (human epididymis secretory protein) gene 17 kb upstream from the HBD-3 gene. One splice variant of this gene (HE2beta1) encodes a beta-defensin consensus cysteine motif, suggesting it represents a defensin gene product. HE2beta1 mRNA expression was detected in gingival keratinocytes and bronchial epithelia using RT-PCR analysis. The discovery of these novel beta-defensin genes may allow further understanding of the role of defensins in host immunity at mucosal surfaces.
Assuntos
Proteínas de Transporte , Genômica , Proteínas Recombinantes , beta-Defensinas/genética , Adulto , Sequência de Aminoácidos , Antígenos de Superfície/genética , Sequência de Bases , Mapeamento de Sequências Contíguas , DNA/química , DNA/genética , Éxons , Feminino , Feto/metabolismo , Expressão Gênica , Regulação da Expressão Gênica no Desenvolvimento , Genes/genética , Biblioteca Genômica , Glicopeptídeos/genética , Glicoproteínas , Humanos , Íntrons , Masculino , Dados de Sequência Molecular , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Alinhamento de Sequência , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Distribuição Tecidual , Proteínas de Transporte VesicularRESUMO
BACKGROUND: Recent studies provide strong evidence implicating Peptostreptococcus micros in the pathogenesis of various oral infections, including oropharyngeal abscesses and periodontal disease. To date, very little is known regarding the role of P. micros in periodontal disease. Therefore, a genetic analysis was initiated to differentiate among strains of P. micros infecting periodontal patients. METHODS: Sixty DNA samples of P. micros isolated from 15 patients with periodontal disease were evaluated. Arbitrarily primed polymerase chain reactions (AP-PCR) were performed using primer 3 (AGTCAGCCAC) and primer 13 (CAGCACCCAC). The PCR products were analyzed by gel electrophoresis. RESULTS: The primers produced several unique patterns among the strains tested. Primer 3 resulted in 30 different patterns, whereas primer 13 resulted in 31 different patterns, which were distinct from those seen with primer 3. In 8 of 15 patients, the PCR profile was identical for all isolates cultured from that patient, indicating a clonal infection. In 4 of 15 patients, 2 different genotypes were identified. In the remaining 3 patients, all isolates cultured from these patients exhibited a unique genotype. CONCLUSIONS: While P. micros appears to be heterogeneous throughout a population of periodontal patients, each patient is, for the most part, infected with a limited number of genotypes. These results demonstrate the genetic diversity of P. micros and the usefulness of AP-PCR for future epidemiological studies in understanding the role P. micros plays in periodontal disease pathogenesis.
Assuntos
Infecções por Bactérias Gram-Positivas/microbiologia , Peptostreptococcus/genética , Periodontite/microbiologia , Adolescente , Adulto , Periodontite Agressiva/microbiologia , Doença Crônica , Primers do DNA , DNA Bacteriano/análise , Placa Dentária/microbiologia , Eletroforese em Gel de Ágar , Variação Genética/genética , Genótipo , Humanos , Funções Verossimilhança , Biologia Molecular , Peptostreptococcus/classificação , Perda da Inserção Periodontal/microbiologia , Bolsa Periodontal/microbiologia , Probabilidade , Técnica de Amplificação ao Acaso de DNA PolimórficoRESUMO
BACKGROUND: Systemic disease and hormonal changes have been implicated as complicating factors for periodontal disease. Diabetes has been identified as a risk factor for periodontal disease, and diabetics can experience periodontal destruction at an earlier age than non-diabetic individuals. Increased hormone levels during pregnancy can contribute to increased gingival inflammation. The purpose of this study was to examine the association of type 1 diabetes mellitus (DM) on the periodontal status of pregnant women. METHODS: Thirty-three (13 diabetic and 20 non-diabetic) subjects, 20 to 39 weeks gestation, participated in this study. The mean age of the diabetics and non-diabetics was 28.5 +/- 7.1 (SD) and 27.0 +/- 7.3 years, respectively. The following parameters were assessed at Ramfjord's reference teeth: plaque index (PI), gingival inflammation (GI), probing depth (PD), gingival margin (GM) location, and clinical attachment level (CAL). RESULTS: Diabetic subjects had significantly (P<0.001) higher PI (1.48 +/- 0.69) and GI (1.77 +/- 0.44) scores than non-diabetics (PI = 0.63 +/- 0.38; GI = 0.93 +/- 0.48). Mean PD for diabetics (2.95 +/- 0.69 mm) was significantly different (P<0.024) from that of non-diabetics (2.44 +/- 0.32 mm). Although mean GM location was coronal to the cemento-enamel junction (CEJ) in both groups, gingival margins were at a more apical position (P<0.001) in the diabetics (-0.20 +/- 1.24 mm) compared to non-diabetics (-1.76 +/- 0.53 mm). Mean CAL values also varied significantly (P<0.001) between diabetics (2.60 +/- 1.54 mm) and non-diabetics (0.68 +/- 0.65 mm). Significant differences were seen for GI (P<0.001), PD (P=0.005), GM location (P<0.001), and CAL (P<0.001) when assessing the effect of diabetes and controlling for plaque. When assessing the effect of plaque and controlling for diabetes, the only significant difference was GI (P=0.001). CONCLUSIONS: The results of this study demonstrate that periodontal inflammation and destruction are increased in pregnant diabetics as compared to non-diabetic pregnant patients. These findings may have implications for diabetic control and, hence, maternal and fetal outcomes in pregnant diabetic patients.
Assuntos
Diabetes Mellitus Tipo 1/complicações , Doenças Periodontais/classificação , Complicações na Gravidez , Gravidez em Diabéticas , Adulto , Análise de Variância , Índice de Placa Dentária , Feminino , Gengiva/patologia , Retração Gengival/classificação , Gengivite/classificação , Humanos , Perda da Inserção Periodontal/classificação , Doenças Periodontais/etiologia , Índice Periodontal , Bolsa Periodontal/classificação , Gravidez , Fatores de Risco , Método Simples-Cego , Estatística como Assunto , Colo do Dente/patologiaRESUMO
INTRODUCTION: Cathelicidins are antimicrobial peptides found in epithelial and mucosal tissues as well as the secondary granules of neutrophils. SMAP29, a sheep cathelicidin, has differential antimicrobial properties against various pathogens, including periodontal organisms. The purpose of this study was to evaluate the antimicrobial properties and cytotoxicity of SMAP29, SMAP28, and three congeners (SMAP18A, SMAP18D, and SMAP14A). METHODS: The peptides at concentrations ranging from 0.25 to 250 microg/ml were tested for their activity against multiple strains of Streptococcus mutans, Streptococcus sanguis, Actinomyces israelii, Actinomyces naeslundii, Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Peptostreptococcus micros, and Porphyromonas gingivalis using a radial diffusion assay. Cytotoxicity of keratinocytes was evaluated by measuring lactate dehydrogenase release after incubation with the individual peptides. RESULTS: SMAP28, thought to be the biologically active peptide, was the most potent antimicrobial (range of minimum inhibitory concentrations 0.06-7.03 microg/ml, P < 0.05); however, the activity of SMAP28 and SMAP29 was strongly associated (r = 0.933). The congeners also demonstrated antimicrobial activity against the bacteria tested (range of minimum inhibitory concnetrations 0.21-79 microg/ml). Overall, F. nucleatum was the most susceptible organism, while P. gingivalis was the least susceptible. Keratinocyte cytotoxicity was dependent on peptide length and dose. SMAP28 was the most cytotoxic, while SMAP14A was the least cytotoxic. CONCLUSION: The antimicrobial activities against oral microorganisms and the minimal toxicity seen in this study suggest that the congeners of SMAP29 may serve as an alternative to traditional antibiotics in the prevention and treatment of periodontal and other oral diseases.
Assuntos
Peptídeos Catiônicos Antimicrobianos/farmacologia , Bactérias Anaeróbias/efeitos dos fármacos , Proteínas Sanguíneas/farmacologia , Catelicidinas/farmacologia , Gengiva/efeitos dos fármacos , Actinomyces/efeitos dos fármacos , Aggregatibacter actinomycetemcomitans/efeitos dos fármacos , Animais , Peptídeos Catiônicos Antimicrobianos/toxicidade , Proteínas Sanguíneas/toxicidade , Catelicidinas/toxicidade , Fusobacterium nucleatum/efeitos dos fármacos , Gengiva/citologia , Humanos , Queratinócitos/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Peptostreptococcus/efeitos dos fármacos , Porphyromonas gingivalis/efeitos dos fármacos , Carneiro Doméstico , Streptococcus/efeitos dos fármacosRESUMO
A panel of five DNA probes has been developed for use in genetic epidemiologic analysis of Actinobacillus actinomycetemcomitans, a bacterium associated with periodontal disease. Restriction fragment length polymorphism profiles were assessed using random genomic probes as well as probes for genes encoding potential virulence factors. These genotypes were compared with serotype and other phenotypic markers. Genotype was shown to be more stable than the phenotypic markers and should prove useful in epidemiological studies of periodontal disease. In addition, the use of a panel of probes has the advantage of being able to distinguish between the occurrence of a new isolate as opposed to a mutation in a strain already characterized. The panel of probes was tested on 35 isolates from humans, 18 isolates from monkeys, and two isolates from a baboon. The genetic probes revealed significant genetic diversity among the A. actinomycetemcomitans isolates. Importantly, most human isolates from an individual genotyped identically, whereas most isolates cultured from a given monkey were different, suggesting that one should exercise caution in comparison of A. actinomycetemcomitans infections in human and non-human primates.
Assuntos
Aggregatibacter actinomycetemcomitans/genética , Sondas de DNA , Polimorfismo de Fragmento de Restrição , Aggregatibacter actinomycetemcomitans/isolamento & purificação , Aggregatibacter actinomycetemcomitans/patogenicidade , Animais , Southern Blotting , Genes Bacterianos , Genótipo , Humanos , Doenças Periodontais/microbiologia , Fenótipo , Primatas , Especificidade da Espécie , Virulência/genéticaRESUMO
Actinobacillus actinomycetemcomitans is a facultative anaerobe implicated in a variety of periodontal diseases. Its presence is most closely associated with localized juvenile periodontitis (LIP), although the exact role of the organism in this and other periodontal diseases is not entirely clear. While A. actinomycetemcomitans produces several different putative virulence factors, the most widely studied is the leukotoxin. The leukotoxin selectively kills polymorphonuclear leukocytes and macrophages in vitro, constituting the host's first line of defense. Interestingly, even though all strains of A. actinomycetemcomitans have the genes encoding the leukotoxin, there is variability in leukotoxin expression. Differences in the structure of the promoter region of the leukotoxin gene operon were shown to correlate directly with levels of leukotoxin production. Highly leukotoxic forms appear to exhibit increased pathogenic potential, as evidenced by recent studies that have shown a significant association between the prevalence of such strains and the occurrence of LIP in several different populations. This represents the first demonstration of an association between a particular subset of a pathogenic species and a specific periodontal disease. Early identification of A. actinomycetemcomitans by microbial and genetic assays to evaluate leukotoxicity may enhance the efficacy of preventive and/or therapeutic techniques. Future investigations should continue to evaluate pathogenic variations of additional virulence factors expressed in vivo, not only of A. actinomycetemcomitans, but also of other periodontal bacteria and infectious disease pathogens.
Assuntos
Aggregatibacter actinomycetemcomitans/patogenicidade , Periodontite Agressiva/microbiologia , Citotoxinas/biossíntese , Exotoxinas/biossíntese , Periodontite Agressiva/epidemiologia , Periodontite Agressiva/imunologia , Animais , Citotoxinas/genética , Exotoxinas/genética , Humanos , Pleuropneumonia/genética , Suínos , VirulênciaRESUMO
The periodontal pathogen, Actinobacillus actinomycetemcomitans, produces leukotoxin, a protein that specifically lyses host defense cells. The leukotoxin is similar in sequence and operon organization to the Escherichia coli alpha-hemolysin and other members of the RTX family of toxins. However, unlike the other RTX toxins, the A. actinomycetemcomitans leukotoxin is not secreted from the cell and instead remains associated with the outer membrane. Nonetheless, the A. actinomycetemcomitans Ikt operon contains two genes, IktB and IktD, that appear analagous to the toxin localization genes found in the other Gram-negative bacteria. Thus, to determine the roles of these putative transport genes in A. actinomycetemcomitans, we have used insertional mutagenesis to generate mutant strains lacking functional LktB and/or LktD. When either IktD or both IktB and IktD were inactivated, the level of detectable leukotoxin protein in the cell decreased significantly. However, the IktB and IktD mutations had no effect on the levels of leukotoxin RNA. Thus, the lack of LktB and LktD proteins must affect LktA synthesis post-transcriptionally. It is proposed that this is an indirect effect of leukotoxin mislocalization in IktB- and IktD- mutants. Finally, analysis of the mutants revealed that LktB and LktD are not essential for the formation of extracellular membrane vesicles in A. actinomycetemcomitans.
Assuntos
Aggregatibacter actinomycetemcomitans/genética , Proteínas de Bactérias/genética , Toxinas Bacterianas/metabolismo , Proteínas de Transporte , Exotoxinas/metabolismo , Proteínas de Membrana Transportadoras , Aggregatibacter actinomycetemcomitans/química , Aggregatibacter actinomycetemcomitans/metabolismo , Proteínas de Bactérias/fisiologia , Toxinas Bacterianas/farmacologia , Transporte Biológico , Membrana Celular/metabolismo , Citotoxinas/metabolismo , Citotoxinas/farmacologia , Análise Mutacional de DNA , Exotoxinas/farmacologia , Genes Bacterianos/genética , Mutagênese Insercional , RNA Bacteriano/biossíntese , RNA Mensageiro/biossínteseRESUMO
Peptostreptococcus micros, an anaerobic gram-positive coccus, has been associated with periodontal and endodontic lesions, including those refractory to treatment, as well as many human polymicrobial infections in other body locations. A selective and differential medium for the primary isolation of P. micros was developed and evaluated. Columbia CNA agar, a selective medium for gram-positive cocci, was supplemented with glutathione and lead acetate (P. micros medium: PMM). P. micros has a characteristic of rapidly utilizing the reduced form of glutathione to form hydrogen sulfide, which reacts with lead acetate producing a black precipitate in the medium. When grown on PMM, P. micros can be easily identified by its typical colonial morphology and the presence of a black precipitate directly under the colony. PMM was compared for the growth of P. micros with phenylethyl alcohol agar (PEA) and Columbia base medium (CBM) with 80 strains of P. micros and 30 strains of other gram-positive cocci. All P. micros isolates tested grew and showed the typical morphology of P. micros on PMM. Using colony counts on CBM as controls, there was an average 81.8% recovery in the number of P. micros colonies on PMM, in contrast to an average 6.1% recovery on PEA. Subgingival plaque and tongue samples from 12 adult periodontitis and 6 early-onset periodontitis patients were cultured onto PMM for the isolation of P. micros. P. micros was isolated on PMM and identified biochemically and enzymatically from both adult periodontitis and early-onset periodontitis patients with higher percentages isolated from the diseased periodontal pockets of adult periodontitis patients; furthermore, this is the first isolation of P. micros from tongue samples taken from periodontally diseased patients. This medium in cultural studies will further our understanding and assist future investigations of P. micros involved in disease processes.
Assuntos
Peptostreptococcus/isolamento & purificação , Periodontite/microbiologia , Ágar , Análise de Variância , Técnicas Bacteriológicas , Contagem de Colônia Microbiana , Meios de Cultura , Placa Dentária/microbiologia , Estudos de Avaliação como Assunto , Glutationa/metabolismo , Humanos , Sulfeto de Hidrogênio/metabolismo , Compostos Organometálicos , Peptostreptococcus/crescimento & desenvolvimento , Peptostreptococcus/metabolismo , Sensibilidade e Especificidade , Staphylococcus/isolamento & purificação , Estatísticas não Paramétricas , Streptococcus/isolamento & purificação , Língua/microbiologiaRESUMO
This study evaluated the expression and regulation of beta-defensins DEFB-104 and the recently identified DEFB-105-14 in gingival keratinocytes. Keratinocytes from healthy subjects were exposed to cytokines, Escherichia coli lipopolysaccharide or Candida species. Total RNA was extracted and defensin expression analyzed by reverse transcription-polymerase chain reaction. Three patterns of expression were seen: no expression, constitutive expression and inducible expression. Constitutive mRNA expression was evident for DEFB-104, 107, 109, 111, and 112. DEFB-108 and 114 were induced by interleukin (IL)-1beta and Candida species. For DEFB-108 expression, synergism was observed when IL-1beta was combined with tumor necrosis factor-alpha or interferon-gamma. Downregulation of DEFB-109 occurred following treatment with Candida albicans. These findings suggest a role for multiple beta-defensins in response to oral infection. Further investigation is needed to better understand their function, both in terms of antimicrobial activities and contributions to innate and acquired immunity.
Assuntos
Anti-Infecciosos/análise , Gengiva/metabolismo , Queratinócitos/metabolismo , beta-Defensinas/análise , Candida/fisiologia , Candida albicans/fisiologia , Citocinas/farmacologia , Regulação para Baixo , Escherichia coli , Expressão Gênica/genética , Regulação da Expressão Gênica/genética , Humanos , Interferon gama/farmacologia , Interleucina-1/farmacologia , Lipopolissacarídeos/farmacologia , RNA Mensageiro/análise , Fator de Necrose Tumoral alfa/farmacologia , beta-Defensinas/genéticaRESUMO
The effects of cathelicidins against oral bacteria and clinically important oral yeasts are not known. We tested the susceptibilities of Actinobacillus actinomycetemcomitans, Fusobacterium nucleatum, Porphyromonas gingivalis, Streptococcus sanguis, Candida krusei, Candida tropicalis and Candida albicans to the following cathelicidins: FALL39, SMAP29, and CAP18. SMAP29 and CAP18 were antimicrobial, whereas FALL39 did not exhibit antimicrobial activity. Future studies are needed to determine the potential use of these antimicrobial peptides in prevention and treatment of oral infections.
Assuntos
Antibacterianos/farmacologia , Bactérias/efeitos dos fármacos , Mamíferos/metabolismo , Boca/microbiologia , Leveduras/efeitos dos fármacos , Animais , Peptídeos Catiônicos Antimicrobianos/farmacologia , Catelicidinas , Contagem de Colônia Microbiana , Testes de Sensibilidade MicrobianaRESUMO
The severity of periodontal disease is dependent on a combination of host, microbial agent and environmental factors. One strong correlate related to periodontal disease pathogenesis is the immune status of the host. Here we show that human neutrophil peptide (HNP) defensins or human beta-defensins (HBD), co-administered intranasally with the antigen ovalbumin (OVA), induce unique immune responses that if used with microbial antigens may have the potential to hinder the pathogenesis of periodontal disease. C57BL/6 mice were immunized intranasally with phosphate buffered saline (PBS) containing 1 micro g HNP-1, HNP-2, HBD1 or HBD2 with and without 50 microg OVA. At 21 days, isotypes and subclasses of OVA-specific antibodies were determined in saliva, serum, nasal wash, bronchoalveolar lavage fluid, and fecal extracts. OVA-stimulated splenic lymphoid cell cultures from immunized mice were assessed for interferon (IFN)-gamma, Interleukin (IL)-4 and IL-10. In comparison with mice immunized with only OVA, HNP-1 and HBD2 induced significantly higher (P < 0.05) OVA-specific serum IgG, lower, but not significant, serum IgM and significantly lower (P < 0.05) IFN-gamma. In contrast, HNP-2 induced low OVA-specific serum IgG and higher, but not significant, serum IgM. HBD1 induced significantly higher (P < 0.05) OVA-specific serum IgG, higher, but not significant, serum IgM, and significantly higher (P < 0.05) IL-10. The elevated serum IgG subclasses contained IgG1 and IgG2b.
Assuntos
Adjuvantes Imunológicos/farmacologia , Defensinas/imunologia , Doenças Periodontais/prevenção & controle , Análise de Variância , Animais , Anticorpos/análise , Anticorpos/sangue , Líquido da Lavagem Broncoalveolar/imunologia , Defensinas/farmacologia , Fezes/química , Feminino , Humanos , Imunidade Ativa/efeitos dos fármacos , Imunoglobulina G/análise , Imunoglobulina G/sangue , Imunoglobulina M/análise , Imunoglobulina M/sangue , Interferon gama/análise , Interleucinas/análise , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos , Ovalbumina/imunologia , Doenças Periodontais/imunologia , Saliva/imunologia , alfa-Defensinas/imunologia , beta-Defensinas/imunologiaRESUMO
beta-Defensins are cationic peptides with broad-spectrum antimicrobial activity that are produced by epithelia at mucosal surfaces. Two human beta-defensins, HBD-1 and HBD-2, were discovered in 1995 and 1997, respectively. However, little is known about the expression of HBD-1 or HBD-2 in tissues of the oral cavity and whether these proteins are secreted. In this study, we characterized the expression of HBD-1 and HBD-2 mRNAs within the major salivary glands, tongue, gingiva, and buccal mucosa and detected beta-defensin peptides in salivary secretions. Defensin mRNA expression was quantitated by RNase protection assays. HBD-1 mRNA expression was detected in the gingiva, parotid gland, buccal mucosa, and tongue. Expression of HBD-2 mRNA was detected only in the gingival mucosa and was most abundant in tissues with associated inflammation. To test whether beta-defensin expression was inducible, gingival keratinocyte cell cultures were treated with interleukin-1beta (IL-1beta) or bacterial lipopolysaccharide (LPS) for 24 h. HBD-2 expression increased approximately 16-fold with IL-1beta treatment and approximately 5-fold in the presence of LPS. Western immunoblotting, liquid chromatography, and mass spectrometry were used to identify the HBD-1 and HBD-2 peptides in human saliva. Human beta-defensins are expressed in oral tissues, and the proteins are secreted in saliva; HBD-1 expression was constitutive, while HBD-2 expression was induced by IL-1beta and LPS. Human beta-defensins may play an important role in the innate defenses against oral microorganisms.